Caledonia Mining Corporation Plc (CMCL) Q3 2025 Earnings Call Transcript — Neutral
CMCL Seeking Alpha — November 10, 2025Caledonia Mining Corporation Plc ( CMCL ) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST Company Participants Mark Learmonth - CEO & Non-Independent Director James Mufara - Chief Operating Officer Ross Ian Jerrard - Chief Financial Officer Craig Harvey - Vice President of Technical Services Conference Call Participants Nic Dinham - SBG Securities (Proprietary) Limited, Research Division Tate Sullivan - Maxim Group LLC, Research Division Presentation Operator Good afternoon, and welcome to the Q3 2025 results presentation for Caledonia Mining. Today, we're joined by Mark Learmonth, who's the CEO, and he's going to introduce the webinar and start …
Ongoing Securities Investigation into Molina Healthcare, Inc. (MOH) - Contact Levi & Korsinsky — Neutral
MOH Newsfile Corp — November 10, 2025New York, New York--(Newsfile Corp. - November 10, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE: MOH) concerning possible violations of federal securities laws. On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its guidance for the third time this year, citing cost pressure and underperformance.
FITNESS CHAMPS HOLDINGS LIMITED ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER REGARDING MINIMUM PRICE DEFICIENCY — Neutral
FCHL GlobeNewsWire — November 10, 2025SINGAPORE, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Fitness Champs Holdings Limited (“FCHL” or the “Company”) (Nasdaq: FCHL), a distinguished aquatic sports education provider in Singapore, today announced that it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated November 6, 2025, notifying the Company that based on the closing bid price of the Company for the period from September 24, 2025 to November 5, 2025, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.
James Hardie (NYSE: JHX) Securities Class Action: Johnson Fistel Reminds Investors of December 23 Deadline to Seek Lead Plaintiff Appointment — Neutral
JHX GlobeNewsWire — November 10, 2025SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired James Hardie Industries plc (NYSE: JHX) common stock or American Depositary Shares between May 20, 2025 and August 18, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses for investors under the federal securities laws.
PNC Bank has launched a partnership with spend/expense management platform Extend. The collaboration, announced Monday (Nov. 10), is aimed at offering new payment capabilities to PNC's commercial clients.
NORTH READING, Mass.--(BUSINESS WIRE)--Teradyne, Inc. (NASDAQ:TER) today announced a quarterly cash dividend of $0.12 per share, payable on December 17, 2025, to shareholders of record as of the close of business on November 24, 2025. About Teradyne Teradyne (NASDAQ:TER) designs, develops, and manufactures automated test equipment and advanced robotics systems. Its test solutions for semiconductors and electronics products enable Teradyne's customers to consistently deliver on their quality sta.
Class Action Alert: Levi & Korsinsky Reminds WPP (WPP) Investors of December 8, 2025 Deadline — Neutral
WPP Newsfile Corp — November 10, 2025New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your WPP plc (NYSE: WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=176576&wire=5&utm_campaign=17 or contact Joseph E. Levi, Esq.
Johnson Fistel Continues Investigation on Behalf of Live Nation Entertainment, Inc. Shareholders — Neutral
LYV GlobeNewsWire — November 10, 2025SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into certain board members and executive officers of Live Nation Entertainment, Inc. (NYSE: LYV) for potential breaches of fiduciary duties and violations of the federal securities laws.
Exclusive: C3 AI weighs sale after founder-CEO Siebel steps aside, sources say — Neutral
AI Reuters — November 10, 2025Enterprise artificial intelligence software provider C3 AI is exploring a potential sale, among other options, after founder Thomas Siebel recently stepped down as CEO over health concerns, according to three people familiar with the matter.
Village Farms International, Inc. (VFF) Q3 2025 Earnings Call Transcript — Neutral
VFF Seeking Alpha — November 10, 2025Village Farms International, Inc. ( VFF ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Mike DeGiglio - Founder, CEO, President & Director Steve Ruffini - CFO, Executive VP, Company Secretary & Director Ann Gillin Lefever - Chief Opearating Officer Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning, ladies and gentlemen. Welcome to Village Farms International Third Quarter 2025 Financial Results Conference Call.
Trinity Industries: Attractive Yield And A Possible Market Recovery — Positive
TRN Seeking Alpha — November 10, 2025Trinity Industries stands out in the transportation equipment sector, showing resilience with strong leasing performance and a substantial industry backlog. TRN's leasing segment benefits from high utilization and rising lease rates, while manufacturing faces weak demand but improved margins and cost controls. The stock trades below sector valuations while its dividend yield is near historical highs, potentially offering an attractive entry point for investors.
Tyson Warns Of Plummeting Consumer Beef Purchases—As Chicken Sales Soar — Neutral
TSN Forbes — November 10, 2025Shares of Tyson Foods rose modestly Monday after the company posted mixed results in its fourth quarter and reported chicken sales have reached a three-year high amid a drop in demand for beef as prices rise.
Class Action Lawsuit Filed Against Fortinet, Inc. (FTNT) - Recover Losses - Contact Levi & Korsinsky Before November 21, 2025 — Neutral
FTNT Newsfile Corp — November 10, 2025New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Fortinet, Inc. (NASDAQ: FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=176577&wire=5&utm_campaign=9 or contact Joseph E. Levi, Esq.
Burger King Follows Familiar Game Plan for China Expansion: Find a Partner — Positive
QSR Barrons — November 10, 2025Burger King's parent company is doing a joint venture with a Chinese investment firm to inject new capital to expand the burger chain's business in China.
Securities Lawsuit Alert: Inspire Medical Systems, Inc. (INSP) Investors - Contact Levi & Korsinsky Before January 5, 2026 — Neutral
INSP Newsfile Corp — November 10, 2025New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=176578&wire=5&utm_campaign=2 or contact Joseph E. Levi, Esq.
Class Action Filed Against Avantor, Inc. (AVTR) - December 29, 2025 Deadline to Join – Contact The Gross Law Firm — Neutral
AVTR GlobeNewsWire — November 10, 2025NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Avantor, Inc. (NYSE: AVTR). Shareholders who purchased shares of AVTR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
DexCom, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights – DXCM — Neutral
DXCM GlobeNewsWire — November 10, 2025NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
Kymera Therapeutics, Inc. (KYMR) Presents at UBS Global Healthcare Conference 2025 Transcript — Neutral
KYMR Seeking Alpha — November 10, 2025Kymera Therapeutics, Inc. ( KYMR ) UBS Global Healthcare Conference 2025 November 10, 2025 11:45 AM EST Company Participants Jared Gollob - Chief Medical Officer Conference Call Participants Xiaochuan Dai - UBS Investment Bank, Research Division Presentation Xiaochuan Dai UBS Investment Bank, Research Division All right. Well, thank you, everyone, for joining us in our fireside chat with Kymera Therapeutics.
KE Holdings Inc. (BEKE) Q3 2025 Earnings Call Transcript — Neutral
BEKE Seeking Alpha — November 10, 2025KE Holdings Inc. ( BEKE ) Q3 2025 Earnings Call November 10, 2025 7:00 AM EST Company Participants Siting Li - Investor Relations Director & Joint Company Secretary Tao Xu - CFO & Executive Director Yongdong Peng - Co-Founder, Chairman & CEO Conference Call Participants John Lam - UBS Investment Bank, Research Division Griffin Chan - Citigroup Inc., Research Division Jiong Shao - Barclays Bank PLC, Research Division Timothy Zhao - Goldman Sachs Group, Inc., Research Division Presentation Operator Hello, ladies and gentlemen. Thank you for standing by for KE Holdings, Inc. Third Quarter 2025 Earnings Conference Call.
Ionis: Near-Term Launches With Blockbuster Potential Boosts Upside Despite Stock Rally — Positive
IONS Seeking Alpha — November 10, 2025Ionis Pharmaceuticals maintains a Buy rating as its transformation to a commercial company accelerates, driven by wholly-owned product launches and revenue growth. Q3 results highlight a revenue shift toward Ionis-owned drugs, with Tryngolza outperforming and Dawnzera launching as a differentiated HAE prophylactic. Olezarsen's strong Phase 3 data in sHTG positions IONS for a blockbuster opportunity, despite market competition and ongoing patent litigation with Arrowhead.